Posts tagged with ‘pharmaceutical’

  • Aquapharm and Dundee University Sign Research Collaboration to find Marine Compounds to target Alzheimer’s

    Aquapharm Biodiscovery, a leading marine biotechnology company, recently announced it has signed a research agreement with Dundee University to help it develop new drugs based on marine natural products that may help in the fight against Alzheimer’s. Alzheimer’s is a disease marked by the formation of insoluble protein aggregates in the brain with associated progressive degeneration of the neurons. The […]
    0
  • New Aker JV to acquire EPAX in €70 million deal

    Newly formed Trygg Pharma – a joint venture between krill player Aker BioMarine and New York-based private investment firm Lindsay Goldberg – has agreed to pay NOK 561 million (€71.2 million) for the Epax shares. Trygg will also assume the net interest bearing debt of Epax, which was NOK 314 million (€39.8 million) as of 31 December 2009. The transaction […]
    0
  • Chitosan-based, nanoparticle gene-silencing system blocks production of protein involved in formation of ovarian cancer cell tumor

    A protein associated with cancer progression when abundant inside of tumors also unexpectedly regulates the creation of new blood vessels that feed the tumor outside, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the August edition of Cancer Cell. Using a chitosan-based, nanoparticle gene-silencing system to block production of the protein, […]
    0
  • Sponge Genome Reveals Animal, Cancer Origins

    In a paper appearing in the recent issue of the journal Nature, a team of researchers led by Daniel Rokhsar of the Univ. of California, Berkeley, and the Department of Energy’s Joint Genome Institute (JGI), report the draft genome sequence of the sea sponge Amphimedon queenslandica and several insights the genome gives into the origins of both the first animals and […]
    0
  • MDPI Office of the Publisher announces publication of new Marine Drugs issue

    MDPI announces publication of the following issue: Mar. Drugs, Volume 8, Issue 7 (July 2010), Pages 1962-2222 at http://www.mdpi.com/1660-3397/8/7/ Table of Contents: Jiali Zhang, Wenshui Xia, Ping Liu, Qinyuan Cheng, Talba Tahi, Wenxiu Gu and Bo Li Review: Chitosan Modification and Pharmaceutical/Biomedical Applications Mar. Drugs 2010, 8(7), 1962-1987; doi:10.3390/md8071962 http://www.mdpi.com/1660-3397/8/7/1962 Feisal Khoushab and Montarop Yamabhai Review: Chitin Research Revisited Mar. […]
    0
  • CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO

    CMP Therapeutics announces the appointment of Dr Neill Moray Mackenzie to the role of Chief Executive Officer. Dr Mackenzie brings to CMPT a long record of executive board level management within the biotechnology and pharmaceutical industries at companies including Cambridge Genetics Ltd, Oxford Biomedica plc (an LSE listed company), Avidex Ltd (now Immunocore) and most recently as the SVP for […]
    0
  • Researchers worry that damage to the oceans could mean some species — and whatever chemicals they produce — will be lost before they’re found

    Marc Slattery, a marine biologist by training, looks to sponges and coral as possible sources of drugs. As stationary species in the open ocean, these organisms have developed many chemical defenses to protect themselves. Slattery studies whether those chemicals could protect us, too. Maybe the same compounds that fend off fish could battle viruses, kill bacteria, and even fight cancer. […]
    0
  • MDPI Publishes New Marine Drugs Issue: Volume 8, Issue 6

    MDPI AG announce the publication of the following issue: Mar. Drugs, Volume 8, Issue 6 (June 2010), Pages 1731-1961 at http://www.mdpi.com/1660-3397/8/6/ Table of Contents: Sonia de Caralt, Javier Sánchez-Fontenla, María J. Uriz and Rene H. Wijffels Article: In Situ Aquaculture Methods for Dysidea avara (Demospongiae, Porifera) in the Northwestern Mediterranean Mar. Drugs 2010, 8(6), 1731-1742; doi:10.3390/md8061731 http://www.mdpi.com/1660-3397/8/6/1731 Charles Santhanaraju Vairappan, Takahiro […]
    0
  • Indonesia And US Launch Deep-Sea Expedition

    The first joint expedition by the Republic of Indonesia and the United States to explore unknown deep-sea areas in Indonesian waters is currently  under way. The expedition is the first activity in a multi-year partnership to advance ocean science, technology and education. This is the first expedition of the NOAA Ship Okeanos Explorer, and the first joint international expedition to send […]
    0
  • Trius Therapeutics Awarded U.S. Department of Defense Contract to Develop Novel Antibiotics from Marine Natural Product Libraries

    Trius Therapeutics, Inc. today  that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which […]
    0